Checkpoint inhibitor
Checkpoint inhibitor patent challenges are settled by AZ and BMS
SG Tylor
AstraZeneca has announced the resolution of three lawsuits filed against it by Bristol-Myers Squibb (BMS) and Ono Pharma, alleging patent ...
Nivolumab and Ipilimumab Together Prolong Survival in Metastatic RCC
SG Tylor
Kidney cancer, or renal cell carcinoma (RCC), is one of the most common types of cancer in adults, affecting about ...
How to Counsel Patients on Immunotherapy Discontinuation in RCC
SG Tylor
Immunotherapy has revolutionized the treatment of metastatic renal cell carcinoma (RCC), a type of kidney cancer that is often resistant ...
